Daniel James George, MD

Professor of Medicine
Professor in Surgery
Member of the Duke Cancer Institute
Campus mail Duke Box 103861, Durham, NC 27710
Phone (919) 668-4615
Email address daniel.george@duke.edu

Education and Training

  • Fellow in Medical Oncology, Medicine, Johns Hopkins University, 1995 - 1998
  • Medical Resident, Medicine, Johns Hopkins University, 1992 - 1995
  • M.D., Duke University, 1992

Grants

Publications

Robinson, Timothy J., Jennifer A. Freedman, Muthana Al Abo, April E. Deveaux, Bonnie LaCroix, Brendon M. Patierno, Daniel J. George, and Steven R. Patierno. “Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities..” Clin Cancer Res 25, no. 10 (May 15, 2019): 2963–68. https://doi.org/10.1158/1078-0432.CCR-18-2445.

PMID
30755441
Full Text

Armstrong, Andrew J., Susan Halabi, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, et al. “Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study..” J Clin Oncol 37, no. 13 (May 1, 2019): 1120–29. https://doi.org/10.1200/JCO.18.01731.

PMID
30865549
Full Text

Holl, Eda K., Megan A. McNamara, Patrick Healy, Monika Anand, Raoul S. Concepcion, Coleman D. Breland, Igor Dumbudze, et al. “Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients..” Prostate Cancer and Prostatic Diseases, April 12, 2019. https://doi.org/10.1038/s41391-019-0144-3.

PMID
30980027
Full Text

Den, Robert B., Daniel George, Christopher Pieczonka, and Megan McNamara. “Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection..” Am J Clin Oncol 42, no. 4 (April 2019): 399–406. https://doi.org/10.1097/COC.0000000000000528.

PMID
30844849
Full Text

Labriola, Matthew K., Kristen A. Batich, Jason Zhu, Megan A. McNamara, Michael R. Harrison, Andrew J. Armstrong, Daniel J. George, and Tian Zhang. “Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma..” Clinical Genitourinary Cancer, February 5, 2019. https://doi.org/10.1016/j.clgc.2019.01.017.

PMID
30858035
Full Text

Zhang, Tian, Daniel J. George, and Andrew J. Armstrong. “Precision Medicine Approaches When Prostate Cancer Akts Up..” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 25, no. 3 (February 2019): 901–3. https://doi.org/10.1158/1078-0432.ccr-18-2491.

PMID
30206162
Full Text

George, Daniel J., Jean-Francois Martini, Michael Staehler, Robert J. Motzer, Ahmed Magheli, Frede Donskov, Bernard Escudier, et al. “Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis..” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 25, no. 4 (February 2019): 1165–73. https://doi.org/10.1158/1078-0432.ccr-18-1724.

PMID
30401688
Full Text

Halabi, Susan, Sandipan Dutta, Catherine M. Tangen, Mark Rosenthal, Daniel P. Petrylak, Ian M. Thompson, Kim N. Chi, et al. “Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel..” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 37, no. 5 (February 2019): 403–10. https://doi.org/10.1200/jco.18.01279.

PMID
30576268
Full Text

Conroy, Jeffrey M., Sarabjot Pabla, Mary K. Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, et al. “Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors..” Journal for Immunotherapy of Cancer 7, no. 1 (January 24, 2019). https://doi.org/10.1186/s40425-018-0489-5.

PMID
30678715
Full Text

Bergerot, Cristiane Decat, Dena Battle, Paulo Gustavo Bergerot, Nazli Dizman, Eric Jonasch, Hans J. Hammers, Daniel J. George, et al. “Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma..” Frontiers in Oncology 9 (January 22, 2019). https://doi.org/10.3389/fonc.2019.00011.

PMID
30723705
Full Text

Pages